OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer
Shelby M. Knoche, Gabrielle L. Brumfield, Benjamin T. Goetz, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0273518-e0273518
Open Access | Times Cited: 10
Shelby M. Knoche, Gabrielle L. Brumfield, Benjamin T. Goetz, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0273518-e0273518
Open Access | Times Cited: 10
Showing 10 citing articles:
Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy
Sara Fanijavadi, Mads Thomassen, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 515-515
Open Access | Times Cited: 1
Sara Fanijavadi, Mads Thomassen, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 515-515
Open Access | Times Cited: 1
Knockout of Pro‐Apoptotic BAX and BAK1 Genes in HEK293T Cells Enhances Adeno‐Associated Virus (AAV) Production: AAV2 and AAV9
Sung-Je Park, Seunghyeon Shin, Gui Seung Han, et al.
Biotechnology Journal (2025) Vol. 20, Iss. 1
Closed Access | Times Cited: 1
Sung-Je Park, Seunghyeon Shin, Gui Seung Han, et al.
Biotechnology Journal (2025) Vol. 20, Iss. 1
Closed Access | Times Cited: 1
Pancreatic cancer: failures and hopes—a review of new promising treatment approaches
Vittore Cereda, Mario D’Andrea
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Vittore Cereda, Mario D’Andrea
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Harnessing Histone Deacetylase Inhibitors for Enhanced Cancer Immunotherapy
Fatemeh Hedayat, Elnaz Faghfuri
European Journal of Pharmacology (2025) Vol. 997, pp. 177620-177620
Closed Access
Fatemeh Hedayat, Elnaz Faghfuri
European Journal of Pharmacology (2025) Vol. 997, pp. 177620-177620
Closed Access
ER-phagy mediates the anti-tumoral synergism between HDAC inhibition and chemotherapy
Felix J Gössl, Pierfrancesco Polo, Frederik Helmprobst, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Felix J Gössl, Pierfrancesco Polo, Frederik Helmprobst, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Fundamental concepts of protein therapeutics and spacing in oncology: an updated comprehensive review
Bahareh Farasati Far, Maryam Safaei, Fatemeh Mokhtari, et al.
Medical Oncology (2023) Vol. 40, Iss. 6
Closed Access | Times Cited: 7
Bahareh Farasati Far, Maryam Safaei, Fatemeh Mokhtari, et al.
Medical Oncology (2023) Vol. 40, Iss. 6
Closed Access | Times Cited: 7
Synergistic therapeutics: Co-targeting histone deacetylases and ribonucleotide reductase for enhanced cancer treatment
Manasa Gangadhar Shetty, Padmini Pai, Mythili Padavu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116324-116324
Open Access | Times Cited: 2
Manasa Gangadhar Shetty, Padmini Pai, Mythili Padavu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116324-116324
Open Access | Times Cited: 2
Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC)
Katja Schiedlauske, Alina Deipenbrock, Marc Pflieger, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 752-752
Open Access | Times Cited: 2
Katja Schiedlauske, Alina Deipenbrock, Marc Pflieger, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 752-752
Open Access | Times Cited: 2
Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy
Benigno C. Valdez, Apostolia M. Tsimberidou, Bin Yuan, et al.
Oncotarget (2024) Vol. 15, Iss. 1, pp. 361-373
Open Access | Times Cited: 1
Benigno C. Valdez, Apostolia M. Tsimberidou, Bin Yuan, et al.
Oncotarget (2024) Vol. 15, Iss. 1, pp. 361-373
Open Access | Times Cited: 1
Histone deacetylase inhibitor and PD‑1 blockade synergistically inhibit B‑cell lymphoma progression in mice model by promoting T‑cell infiltration and apoptosis
Tong Wang, Ye Xu, Hao Jiang, et al.
Oncology Reports (2024) Vol. 52, Iss. 4
Closed Access
Tong Wang, Ye Xu, Hao Jiang, et al.
Oncology Reports (2024) Vol. 52, Iss. 4
Closed Access
